Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
VALHALLA, N.Y. and SOUTH PLAINFIELD, N.J., Aug. 08, 2017 -- Today, New York Medical College and Touro College of Pharmacy announced the wider availability of their joint Continuing Medical Education (CME) course, Principles of Genomics and Introduction to Personalized Medicine. The course which premiered live on March 21st, has been archived and is available through webinar with the goal of providing the medical community more exposure to pharmacogenomics (PGx). The CME course was made possible by an educational grant from molecular diagnostic company, Admera Health (www.admerahealth.com).
The course introduces the principles of PGx; specifically, how genetic variability can lead to different drug responses. The course then provides specific clinical case studies in the therapeutic areas of cardiology, oncology, psychiatry, and pain management. Other topics covered are Electronic Health Records and Reimbursement.
“As a leader in healthcare education, the CME program in pharmacogenomics is a natural fit with our institution’s commitment to life-long learning. Through both our curriculum, as well as our extensive research program in pharmacogenomics, Touro provides its students with significant exposure and practical experience in this cutting-edge area. We thank Admera Health for their support towards this initiative,” stated Dr. Zvi Loewy, Professor and Chair Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy and Adjunct Professor, New York Medical College.
“This provides us an avenue to help educate the medical community on the importance of pharmacogenomics. As PGx testing becomes the standard of care, it has the potential to significantly reduce the number of Adverse Drug Events and drive down medical costs,” stated Guanghui Hu, PhD, President and CEO of Admera. Hu continued, “Given our position as the market leader in pharmacogenomics testing, this sponsorship opportunity was perfect fit for us.”
Admera Health offers PGxOne™ Plus testing, a PGx test assaying 50 genes and providing clinical recommendations for over 300 drugs.
About the Touro College and University System
Touro is a system of non-profit institutions of higher and professional education. Touro College was chartered in 1970 primarily to enrich the Jewish heritage, and to serve the larger American and global community. Approximately 18,000 students are currently enrolled in its various schools and divisions. Touro College has 30 campuses and locations in New York, California, Nevada, Berlin, Jerusalem and Moscow. New York Medical College; Touro University California and its Nevada branch campus; Touro University Worldwide and its Touro College Los Angeles division; as well as Hebrew Theological College in Skokie, Ill. are separately accredited institutions within the Touro College and University System. For further information on Touro College, please go to: www.touro.edu/news
About Admera Health
Admera Health is a CLIA-certified and CAP-accredited advanced molecular diagnostics company focused on personalized medicine, non-invasive cancer testing, digital health, and providing research use only services. Research and development efforts are dedicated to developing cutting-edge diagnostics that span the continuum of care. Utilizing next generation technology platforms and advanced bioinformatics, Admera Health seeks to redefine disease screening, diagnosis, treatment, monitoring, and management through its innovative, personalized solutions. It is Admera’s mission to deliver transformative, valuable solutions for patients, physicians, and clinical researchers. Admera health is committed to improving the health and well-being of the global community through the direct delivery of personalized, medically actionable results.
Touro College of Pharmacy Contact Zvi G. Loewy, Ph.D. Professor and Chair Pharmaceutical and Biomedical Sciences 646-981-4718 [email protected] Admera Health Contact: Brady Millican, VP Business Development 908-222-0533 [email protected]
